Outcomes of umbilical cord transplant in high risk relapsed or refractory acute myeloid leukaemia

被引：0
|
作者：
Elbahy, Samar [1 ,2 ]
Bonney, Denise [1 ]
Campbell, Helen [1 ]
Deambrosis, David [1 ]
Wynn, Robert [1 ]
机构：
[1] Royal Manchester Childrens Hosp, Manchester, Lancs, England
[2] Benha Univ, Fac Med, Banha, Egypt
来源：
BONE MARROW TRANSPLANTATION | 2019年 / 54卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P718
引用
收藏
页码：597 / 598
页数：2
相关论文
共 50 条
  • [1] Treatment of relapsed/refractory acute myeloid leukaemia in adults
    Rashidi, Armin
    Weisdorf, Daniel J.
    Bejanyan, Nelli
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 (01) : 27 - 37
  • [2] EXCELLENT SURVIVAL USING T-REPLETE UMBILICAL CORD BLOOD TRANSPLANT IN HIGH RISK PAEDIATRIC MYELOID LEUKAEMIA, INCLUDING IN REFRACTORY DISEASE
    Davies, Kate
    Wynn, Rob
    BONE MARROW TRANSPLANTATION, 2024, 59 : 595 - 596
  • [3] Cord blood transplant for acute myeloid leukaemia
    Ballen, Karen K.
    Lazarus, Hillard
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (01) : 25 - 36
  • [4] Considerations and challenges for patients with refractory and relapsed acute myeloid leukaemia
    Kell, Jonathan
    LEUKEMIA RESEARCH, 2016, 47 : 149 - 160
  • [5] The changing landscape for patients with relapsed/refractory acute myeloid leukaemia
    Isidori, Alessandro
    Ferrara, Felicetto
    CURRENT OPINION IN ONCOLOGY, 2021, 33 (06) : 635 - 641
  • [6] Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adults
    Phillips, Christine L.
    Davies, Stella M.
    McMasters, Richard
    Absalon, Michael
    O'Brien, Maureen
    Mo, Jun
    Broun, Randall
    Moscow, Jeffrey A.
    Smolarek, Teresa
    Garzon, Ramiro
    Blum, William
    Schwind, Sebastian
    Marcucci, Guido
    Perentesis, John P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 161 (03) : 406 - 410
  • [7] Isocitrate dehydrogenase inhibitors as a bridge to allogeneic stem cell transplant in relapsed or refractory acute myeloid leukaemia
    Genthon, Alexis
    Dragoi, Diana
    Memoli, Mara
    Hirsch, Pierre
    Favale, Fabrizia
    Suner, Ludovic
    Chaquin, Michael
    Boncoeur, Pierre
    Marjanovic, Zora
    Bonnin, Agnes
    Sestili, Simona
    Dulery, Remy
    Malard, Florent
    Brissot, Eolia
    Banet, Anne
    van de Wyngaert, Zoe
    Vekhoff, Anne
    Delhommeau, Francois
    Mohty, Mohamad
    Legrand, Ollivier
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 198 (04) : 780 - 784
  • [8] Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemia
    Thomas, DA
    Estey, E
    Giles, FJ
    Faderl, S
    Cortes, J
    Keating, M
    O'Brien, S
    Albitar, M
    Kantarjian, H
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 123 (03) : 436 - 441
  • [9] FLT3 inhibitors for relapsed or refractory acute myeloid leukaemia
    Stein, Eytan M.
    LANCET ONCOLOGY, 2018, 19 (07): : 849 - +
  • [10] Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia
    Eric Tse
    Anskar Y. H. Leung
    Joycelyn Sim
    Harold K. K. Lee
    Herman S. Y. Liu
    Sze-Fai Yip
    Yok-Lam Kwong
    Annals of Hematology, 2011, 90 : 1277 - 1281
12345